Product Images Clorazepate Dipotassium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Clorazepate Dipotassium NDC 51672-4043 by Taro Pharmaceuticals U.s.a., Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - clorazepate 01

Chemical Structure - clorazepate 01

PRINCIPAL DISPLAY PANEL - 3.75 mg Bottle Label - clorazepate 02

PRINCIPAL DISPLAY PANEL - 3.75 mg Bottle Label - clorazepate 02

PRINCIPAL DISPLAY PANEL - 15 mg Bottle Label - clorazepate 03

PRINCIPAL DISPLAY PANEL - 15 mg Bottle Label - clorazepate 03

PRINCIPAL DISPLAY PANEL - 7.5 mg Bottle Label - clorazepate 04

PRINCIPAL DISPLAY PANEL - 7.5 mg Bottle Label - clorazepate 04

This is a medication called Clorazepate Dipotassium, which comes in a bottle of 100 tablets with 15 mg each. It is a prescription-only drug that requires dispensing the accompanying medication guide to each patient. The recommended dosage and precautions are available in the package insert. It should be stored at room temperature, protected from moisture in a tightly closed container. This medication is manufactured by Taro Pharmaceutical Industries Ltd, located in Haifa Bay, Israel, and distributed by Taro Pharmaceuticals U.S.A., Inc. The trademark registered for this medication is TARO. The second number provided is not clear and cannot be identified.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.